New MRI scan spots hidden fat clues to breast cancer

NCT ID NCT03400215

Ongoing Diagnosis Sponsor: NYU Langone Health Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new, 15-minute MRI scan that measures the types of fat in breast tissue. Researchers want to see if women with breast cancer have more saturated fat in their breasts than women with benign lumps. About 190 postmenopausal women will get the extra scan during their regular breast MRI. If the method works, it could offer a new, non-invasive way to assess breast cancer risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Gradient-echo Spectroscopic Imaging (GSI) MRI scan
What this could lead to: If successful, this could lead to a non-invasive way to assess breast cancer risk by measuring breast fat composition during a routine MRI.
What could go wrong: This is an observational study, not a treatment trial. The results may not lead to a direct clinical test, and the link between breast fat and cancer risk is still unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

NYU Langone Health

New York, New York, 10016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.